Stoke Therapeutics, Inc. Business Finance Contracts & Agreements

12 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Securities Registered Under Section 12 of the Exchange Act – Stoke Therapeutics, Inc.
Registration Rights Agreements
Stoke Therapeutics, Inc.
Biotechnology
2025
Stoke Therapeutics, Inc. Form of Pre-Funded Warrant to Purchase Common Stock (April 2, 2024)
Warrant Agreements
Stoke Therapeutics, Inc.
Biotechnology
NY
2024
Underwriting Agreement between Stoke Therapeutics, Inc. and J.P. Morgan Securities LLC (March 27, 2024)
Underwriting Agreements
Stoke Therapeutics, Inc.
Biotechnology
NY
2024
Stoke Therapeutics, Inc. 2019 Equity Incentive Plan
Equity Distribution Agreements
Stoke Therapeutics, Inc.
Biotechnology
DE
2023
Description of Securities Registered Under Section 12 of the Exchange Act – Stoke Therapeutics, Inc.
Equity Distribution Agreements
Stoke Therapeutics, Inc.
Biotechnology
2021
Stoke Therapeutics, Inc. Underwriting Agreement for 2,500,000 Shares of Common Stock with J.P. Morgan, Cowen, and Credit Suisse
Underwriting Agreements
Stoke Therapeutics, Inc.
Biotechnology
NY
2020
Description of Registered Securities of Stoke Therapeutics, Inc. under Section 12 of the Exchange Act
Equity Distribution Agreements
Stoke Therapeutics, Inc.
Biotechnology
2020
2019 Employee Stock Purchase Plan, to become effective on the date the registration statement is declared effective, and forms of award agreements
Stock Agreements
Stoke Therapeutics, Inc.
Biotechnology
DE
2019
Form of Common Stock Certificate
Stock Agreements
Stoke Therapeutics, Inc.
Biotechnology
2019
Form of Underwriting Agreement
Underwriting Agreements
Stoke Therapeutics, Inc.
Biotechnology
NY
2019
Description of Securities Registered Under Section 12 of the Exchange Act – Stoke Therapeutics, Inc.
Registration Rights Agreements
Stoke Therapeutics, Inc.
Biotechnology
2024
Amended and Restated Investors Rights Agreement, dated October 22, 2018, by and among the Registrant and certain of its stockholders
Investor Rights Agreements
Stoke Therapeutics, Inc.
Biotechnology
DE
2019